US Supreme Court Reverses Purdue Pharma’s $6 Billion Opioid Settlement, Raising New Questions

Pieter Gunst01 mins

The US Supreme Court has nullified Purdue Pharma LP’s $6 billion opioid settlement, raising further uncertainties for the OxyContin manufacturer by concluding that the agreement improperly protected the Sackler family, who owns the company. The 5-4 verdict disrupts a plan aimed at resolving extensive civil litigation against Purdue Pharma and directing billions towards combatting the opioid crisis. Sackler family members had consented to relinquish ownership of the company and contribute up to $6 billion as part of the now-invalidated deal. For more details, visit the original report on Bloomberg Law.